Article: Company To Suspend Production Of Eye Drops

A manufacturer of eye drops and painkillers has agreed to stop production at its California plant after the Food and Drug Administration cited the company for safety and other problems.

The FDA announced yesterday that MBI Distributing Inc., also known as Molecular Biologics, will no longer make or distribute its drugs until it corrects the violations at its Benicia, Calif., plant. The company agreed to these conditions in a consent decree that still must be approved by a federal court, the agency said.

According to the FDA, the problems with the company's products include:

Eye drops that are not manufactured according to national

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!